Sword Health Raises $163M In Series D; Reaches $2 Billion Valuation

Sword Health, a NYC-based clinical digital musculoskeletal (MSK) company, raised $163m in funding, reaching a $2 Billion valuation.

The round was led by Sapphire Ventures with participation from new investors Sozo Ventures, Willoughby Capital, ADQ and Localglobe, and from all major investors including General Catalyst, Khosla Ventures, Founders Fund, Bond, Transformation Capital, and Green Innovations. This brings the total primary and secondary transactions to more than $320M.

The company intends to use the funds to expand operations and its reach among two billion people suffering from physical pain.

Led by Virgilio Bento, founder and CEO, Sword Health is a virtual musculoskeletal (MSK) care provider, which delivers care to members through Doctors of Physical Therapy and the FDA-listed SWORD Health Digital Therapist. The company recently launched a complete end-to-end clinical solution – SWORD+ – with three features:

  • ASK a PT™, which is a 24/7 solution connecting members with physical therapists to answer general questions about physical pain.
  • Digital Guardian™, which applies wearable and video motion capture components to monitor and correct unsafe movements to prevent workplace injury, and
  • The Academy, which blends Masterclass and customized educational content.

Since launching in 2015, the company has worked with insurers, health systems, and employers in the U.S., Canada, Europe, and Australia to make musculoskeletal care accessible to everyone.